These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7893843)

  • 21. How old is the lesion presenting as schizophrenia? Relevance to the laterality question.
    Bracha HS
    Arch Gen Psychiatry; 1990 Apr; 47(4):393. PubMed ID: 2322089
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders.
    Stanley JA
    Can J Psychiatry; 2002 May; 47(4):315-26. PubMed ID: 12025430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.
    Buckley PF; Moore C; Long H; Larkin C; Thompson P; Mulvany F; Redmond O; Stack JP; Ennis JT; Waddington JL
    Biol Psychiatry; 1994 Dec; 36(12):792-800. PubMed ID: 7893844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease?
    Waddington JL; Lane A; Scully PJ; Larkin C; O'Callaghan E
    Psychiatr Clin North Am; 1998 Mar; 21(1):123-49. PubMed ID: 9551494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Childhood-onset schizophrenia: timely neurobiological research.
    McKenna K; Gordon CT; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1994; 33(6):771-81. PubMed ID: 7521867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Risk for schizophrenia and diagnostic image of cerebral membrane metabolism].
    Klemm S; Gerhard UJ; Blanz B
    Z Kinder Jugendpsychiatr Psychother; 2001 Feb; 29(1):50-8. PubMed ID: 11234552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemispheric asymmetry and the problem of typology of schizophrenia (a review)].
    Kalinin VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(12):101-10. PubMed ID: 2699139
    [No Abstract]   [Full Text] [Related]  

  • 28. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective.
    Lieberman JA
    Biol Psychiatry; 1999 Sep; 46(6):729-39. PubMed ID: 10494440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.
    Duarte JMN; Xin L
    Neurochem Res; 2019 Jan; 44(1):102-116. PubMed ID: 29616444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The promise of epidemiologic studies: neuroimmune mechanisms in the etiologies of brain disorders.
    Ellman LM; Susser ES
    Neuron; 2009 Oct; 64(1):25-7. PubMed ID: 19840544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance spectroscopy and metabolic imaging in white matter diseases and pediatric disorders.
    Cecil KM; Kos RS
    Top Magn Reson Imaging; 2006 Aug; 17(4):275-93. PubMed ID: 17415001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurodevelopmental model of schizophrenia.
    Arch Gen Psychiatry; 1988 Nov; 45(11):1051-4. PubMed ID: 3178412
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative study of proton and phosphorus magnetic resonance spectroscopy in schizophrenia at 4 Tesla.
    Théberge J; Al-Semaan Y; Jensen JE; Williamson PC; Neufeld RW; Menon RS; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2004 Nov; 132(1):33-9. PubMed ID: 15546701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Are schizophrenias psychogenic or organic diseases?].
    Leonhard K
    Recenti Prog Med; 1970 Mar; 48(3):235-47. PubMed ID: 5467920
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversible cortical oedema mimicking cortical dysplasia in mitochondrial disorder.
    Tuxhorn I; Holthausen H; Ebner A; Noachtar S
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1439. PubMed ID: 7964834
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical structure of the initial stages of schizophrenia developing against a background of residual cerebral insufficiency].
    Mikhlin VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(3):423-9. PubMed ID: 4156989
    [No Abstract]   [Full Text] [Related]  

  • 37. [Magnetic resonance--more than just images! New MR techniques improve diagnosis, therapeutic control and assessment of brain function].
    Holtäs S; Ståhlberg F
    Lakartidningen; 1998 Jan; 95(4):266-70. PubMed ID: 9469959
    [No Abstract]   [Full Text] [Related]  

  • 38. Molybdenum-cofactor deficiency: CT and MR findings.
    Schuierer G; Kurlemann G; Bick U; Stephani U
    Neuropediatrics; 1995 Feb; 26(1):51-4. PubMed ID: 7791952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neurodevelopmental theory of schizophrenia: evidence from studies of early onset cases.
    Kinros J; Reichenberg A; Frangou S
    Isr J Psychiatry Relat Sci; 2010; 47(2):110-7. PubMed ID: 20733253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain cell membrane motion-restricted phospholipids: a cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia.
    Puri BK; Counsell SJ; Hamilton G
    Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):233-5. PubMed ID: 18842398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.